Critical Analysis: Hyperfine (HYPR) Vs the Competition

Hyperfine (NASDAQ: HYPR – Receive Rating) is one of 69 public companies in the “electromedical equipment” industry, but how does it stack up against its competitors? We will compare HyperFine to related businesses based on the strength of its analyst recommendations, institutional ownership, risk, earnings, dividends, profitability and valuations.

volatility and risk

Hyperfine has a beta of 0.69, suggesting that its share price is 31% less volatile than the S&P 500. By comparison, Hyperfine’s competitors have a beta of 13.35, suggesting that their average share price is 1,235% more volatile than the S&P 500.

Earnings and Valuation

This table compares HyperFine and its competitors’ gross revenue, earnings per share and valuation.

Gross revenue Net income price earnings ratio
very subtle $1.50 million -$64.85 million -0.22
hyperfine competitor $1.03 billion $130.62 million -0.49
Want more great investment ideas?

Hyperfine’s competitors have higher revenue and earnings than Hyperfine. HyperFine is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.


This table compares Net Margin, Return on Equity and Return on Assets of HyperFine and its competitors.

net margin Dividend return on assets
very subtle -1,479.40% -54.01% -49.87%
hyperfine competitor -694.90% -44.28% -25.30%

analyst rating

Here is a summary of the recent ratings and target prices provided by MarketBeat for HyperFine and its competitors.

sell rating keep rating buy rating strong buy rating rating score
very subtle 0 1 2 0 2.67
hyperfine competitor 88 598 1654 76 2.71

HyperFine currently has a consensus price target of $4.30, suggesting a potential upside of 437.43%. As a group, “electromedical equipment” companies have a potential growth of 83.93%. Given the high potential for Hyperfine, research analysts clearly believe Hyperfine is more favorable than its competitors.

Institutional and Insider Ownership

23.9% of HyperFine shares are owned by institutional investors. By comparison, 44.7% of all “electromedical equipment” companies are owned by institutional investors. 26.1% of Hyperfine’s shares are owned by insiders. By comparison, 11.3% of the shares of all “electromedical equipment” companies are owned by insiders. Strong institutional ownership is a sign that endowments, large money managers and hedge funds believe the stock is poised for long-term growth.


HyperFine competitors beat HyperFine on 10 of the 13 factors compared.

About HyperFine

(get rating)

Hyperfine, Inc. Provides imaging, surveillance and magnetic resonance imaging products. It offers the Swoop Portable MR Imaging System to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.

Receive news and ratings for HyperFine Daily – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for Hyperfine and related companies with’s FREE daily email newsletter.

Leave a Comment

Your email address will not be published.

Then We Knew It Was on..” – Roman Reigns Shark Tank Keto Gummies Scam Alert? McDonald’s Halloween Buckets Could Be Back How to Watch Spacecraft Collide With Deep Space Asteroid Grand Theft Auto VI footage leaked after the hack Floyd Mayweather Jr boxer knocks out Mikuru Asakura martial artist